lippard glutathione cisplatin

lippard glutathione cisplatin Molecular mechanisms of resistance Cisplatin in cancer therapy: molecular

Name: lippard glutathione cisplatin Molecular mechanisms of resistance Cisplatin in cancer therapy: molecular
Brand: reganhouse.co.nz
SKU: 34734626398
Price: 27.28 USD
Availability: InStock
Rating: 4.6921 (12 reviews)

Cisplatin in cancer therapy: molecular mechanisms of action PMC Is Glutathione the Major Cellular Target of Cisplatin? A Study of the Interactions of Cisplatin with Cancer Cell Extracts Journal of Medicinal Chemistry Overcoming resistance to cisplatin by inhibition of glutathione S transferases (GSTs) with ethacraplatin micelles in vitro and in vivo ScienceDirect PDB 101: Molecule of the Month: Cisplatin and DNA Cisplatin based combination therapy for cancer : Journal of Cancer Research and Therapeutics Bucillamine prevents cisplatin induced ototoxicity through induction of glutathione and antioxidant genes Experimental & Molecular Medicine

SKU: 34734626398 · From reganhouse.co.nz

4.7

USD27.28 USD64.28

Pay in 4 interest-free payments of $6.82 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

It accommodates two epidermal appendages: the pilosebaceous unit, composed of hair follicles (HF) and sebaceous glands, and the sweat glands

Effect of ecklonia Cava polyphenol extract in house ear institute-organ of Corti 1 cells against cisplatin ototoxicity: a preliminary study

J Reprod Infertil

TRIMs are major regulators of autophagic processes, and their autophagic actions may constitute another TRIM-dependent contribution to cancer stemness

[24] constructed an osteoporosis rat model through bilateral ovariectomy in female SD rats and, after treatment by intraperitoneal gavage with icariin, upregulated the protein expression levels of serum OC, BALP and bone tissues Beclin1, LC3-II and Bcl-2 while downregulating the protein expression levels of serum TRAP, NTX-I and bone tissues P62, caspase-3 and Bax